This follows earlier delays in DSCSA enforcement, with many pharmacies noting they were not ready to comply with the law. The law aims to enhance the tracking of packaged therapies and grant the FDA more power to regulate compounded medications.
Here are four developments regarding the delayed enforcement:
- The exemption applies to trading partners that have made documented efforts to establish data connections with their immediate partners but still encounter difficulties.
- Separate deadlines have been set for various trading partners, with manufacturers and repackagers needing to comply by May 27, 2025, wholesale distributors by Aug. 27, 2025 and dispensers with 26 or more full-time employees by Nov. 27, 2025.
- Trading partners utilizing the exemptions are not obligated to inform the FDA about their use of them.
- The move is part of the FDA’s efforts to prevent supply chain disruptions and ensure patients receive medications without delays amid ongoing concerns about pharmacy readiness.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
